CITAZA 100MG INJECTION

Content Reviewed By:

Written By:

• In Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML), the abnormal proliferation of tumor cells stems from transcriptional repression, a process significantly influenced by DNA hypermethylation. This hypermethylation essentially silences genes that would normally regulate cell growth and differentiation, leading to uncontrolled cellular expansion characteristic of these cancers. Transcriptional repression involves proteins binding to DNA, either directly or indirectly, to suppress the transcription – or copying – of specific genes or sets of genes. This mechanism prevents the production of essential proteins that would otherwise inhibit tumor development.
• CITAZA 100MG INJECTION, in its active form, exerts its therapeutic effect by directly interacting with both RNA and DNA within the body. This interaction disrupts the normal function of these nucleic acids, particularly in rapidly dividing cells, such as cancer cells. By interfering with RNA and DNA activity, CITAZA 100MG INJECTION effectively inhibits cell division and induces a toxic effect, ultimately leading to the death of cancerous cells. This targeted action helps to control the growth and spread of MDS and AML.
• The drug's mechanism of action specifically targets the epigenetic modifications that drive tumor development in MDS and AML. By reversing or inhibiting DNA hypermethylation, CITAZA 100MG INJECTION aims to restore the expression of silenced genes, thereby promoting normal cellular function and differentiation. This approach represents a significant advancement in cancer therapy, as it directly addresses the underlying molecular mechanisms that contribute to disease progression. It is important to note that the drug's effectiveness can vary depending on the individual patient and the specific characteristics of their cancer.

• CITAZA 100MG INJECTION should only be administered under the direct supervision and guidance of a qualified physician. Self-administration is strongly discouraged. The dosage will be meticulously determined by your physician, taking into account several crucial factors, including your height, weight, overall health status, and the specific medical condition being treated. It is imperative to adhere strictly to the prescribed dosage and administration schedule provided by your healthcare provider.
• This medication is administered via subcutaneous injection, meaning it is injected beneath the skin. Common injection sites include the thigh, stomach (abdomen), or upper arm. Your physician or a trained healthcare professional will carefully select the most appropriate injection site and will provide detailed instructions on proper injection techniques. If you are administering the injection yourself, ensure you fully understand and follow these instructions to minimize the risk of complications.
• It is crucial to maintain consistent injection sites and to rotate them regularly to prevent skin irritation or other localized reactions. Furthermore, it's important to observe the injection site for any signs of redness, swelling, pain, or infection. If you experience any adverse reactions, promptly consult with your physician. Regular monitoring by your healthcare provider is essential to assess your response to the medication and to make any necessary adjustments to your treatment plan.